ABSTRACT
Image standardization efforts in digital pathology are challenging in that they must encompass software and hardware involved in image acquisition (scanning), manipulation (processing), and display, in addition to the significant variability in the source material that results from histology and staining processes. Recent reviews of end-to-end image standardization efforts 1 highlight significant progress in developing standards for digital slide scanning, but comparatively less work addresses display device requirements. As the pathology transitions to digital workflows, it will be vital to understand if (and how) display quality and calibration affect pathologic diagnosis. Diagnostic radiologists faced similar issues when transitioning from film to computer monitors. As studies revealed that display characteristics have a clear impact on radiologic diagnosis, digital radiology practice was standardized around the DICOM Grayscale Standard Display Function (GSDF)-calibrated medical-grade (MG) monochrome display. 2 The GSDF standard was developed to maximize the diagnostic information ("just noticeable differences") presented to radiologists and to ensure consistency of images viewed at different times, in different places, or with heterogeneous display hardware. The rapidly expanding use of color images throughout medical practice (eg, within radiology, ophthalmology, dermatology, and gastroenterology) has now driven similar initiatives to calibrate displays for interpretation of color data. from that in diagnostic pathology. Two studies examining color calibration of monitors for digital pathology demonstrated that calibration does not affect diagnostic accuracy of breast biopsy specimens. 8, 9 Indeed, a third study, also on breast biopsy specimens, showed that a monochrome display was largely sufficient for an accurate diagnosis. 10 These studies do not conclude that color is an irrelevant image characteristic, but they do raise questions as to the strictness of color representation needed to enable accurate pathologic diagnoses. In contrast, color calibration and MG displays do appear to improve the speed of diagnosis. 9 One study has demonstrated a significant decrease in both time to identification of first diagnostic feature and total diagnostic time when using a composite display with twice the spatial resolution of a baseline display.
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The primary end point of interest in most digital pathology studies has been overall diagnostic accuracy. By contrast, this study was designed to assess whether the ability to identify and quantify small but clinically relevant diagnostic features differs with respect to whether a calibrated MG or commercial-grade monitor is used. Two features for which accurate quantitation or detection has a significant diagnostic and/or prognostic importance, mitotic figures in malignant melanoma and Helicobacter pylori detection in stomach biopsy specimens, were chosen as representative subjects for this study.
Materials and Methods
This study was reviewed and approved by the institutional review board. Skin biopsy specimens with a diagnosis of melanoma (received between January 2014 and July 2014) and random gastric biopsy specimens with and without H pylori bacteria (received between January 2013 and April 2014) were selected to ensure a range of mitotic figures (0-3) or a range of H pylori (none to many) by a board-certified dermatopathologist (T.F.) or board-certified gastrointestinal pathologist (T.M.), respectively ❚Table 1❚. A representative slide with no folds in the tissues and high-quality H&E staining was chosen from each of the cases. A region of interest (ROI) (96,800 µm 2 ) with a desired mitotic or H pylori detection was then selected by the respective study pathologist by light microscopy and captured using an attached digital camera (Olympus DP71 [Olympus, Center Valley, PA]; TIFF format images; 24-bit color; approximately 4 MB in size each; 1,360 × 1,024 pixels). The study dermatopathologist enumerated the visible mitoses in the melanoma ROIs, and the study gastrointestinal pathologist determined the presence or absence of H pylori organisms and quantified the organisms when present (0 = none, 1 = few, 2 = moderate, and 3 = many) in the gastric ROIs.
Nine reviewing pathologists (each with a minimum of 5 years of board-certified experience but no digital sign-out experience) participated in the study; seven pathologists (one dermatopathologist and six pathologists with subspecialty training in other areas) evaluated the melanoma cases, and two gastrointestinal pathologists evaluated the gastric cases. The reviewing pathologists were blinded to the evaluations of the study pathologists. ROIs were evaluated by the reviewing pathologists using a commercial off-theshelf (COTS) Dell U3014 display (Dell, Round Rock, TX) with factory default calibration (gamma, 2. ; contrast ratio, 1,000:1). The pathologists were randomized to a monitor for initial review, and there was a minimum 2-week washout period between reviews. In addition to evaluating the specific features of the ROIs, the pathologists provided a subjective evaluation of color, brightness, and overall quality for each monitor per case using a 5-point Likert-type scale (1 = very poor, 2 = poor, 3 = average, 4 = good, and 5 = very good).
The findings of the study pathologist and each of the reviewing pathologists and agreement between reviewing pathologists' findings using the COTS monitor and MG monitors were evaluated statistically using weighted κ.
Results
For both tasks of mitotic figure enumeration and H pylori burden classification, the level of agreement Ratings for color, brightness, and overall quality were similar between COTS and MG displays for six of the nine pathologists, with 88% or more of the cases reviewed rated as having good or very good color, brightness, and overall quality. Of the three remaining pathologists, the overall quality ratings of the COTS display were higher than the MG display in most cases for two of the pathologists and lower for the third pathologist ❚Table 5❚.
Discussion
For both the COTS and MG color-calibrated display, a high level of agreement between the study pathologist and each evaluating pathologist was observed for both mitotic count and H pylori burden assessments. These data suggest that there is no significant negative impact in using a noncalibrated display for either of these detailed assessment tasks. In addition to improved color accuracy, the MG display used in this study also had superior absolute and spatial resolution and luminance; however, these factors do not appear to have substantially improved pathologist performance for the two assessed tasks. These findings are consistent with those of previous reports demonstrating that color calibration has a limited impact on diagnostic pathology accuracy. A potential limitation of this study is that time to identification of first diagnostic feature and overall interpretation speeds were not assessed.
Mitotic figure counting is considered a difficult task, and there is significant variability in reported mitotic counts between observers. 12, 13 The substantial interobserver and intraobserver agreement observed in this study is likely a result of using confined digital ROIs rather than whole slides or whole-slide images. Overall, the use of ROIs (vs whole slide images) in this study was justified in that ROIs enabled the analysis to be focused on differences inherent to the individuals' monitors by reducing the risk that confounding elements such as search strategy (which studies suggest is influenced to a greater degree by display resolution differences) would influence the results. Nevertheless, use of ROIs is a clear limitation of this work's generalizability to whole-slide evaluation. In addition, it should be noted that no additional calibration of the COTS was performed (ie, the COTS monitor was used with factory settings "out of the box"). Color, contrast, white point, and luminance calibration of a consumer-grade monitor are possible and could potentially have influenced the subjective preference judgments. Finally, this study was focused on the tasks of mitotic counting and H pylori identification, tasks in which color is expected to play an important but limited role. Other display factors (in particular resolution) may be of greater significance in the performance of those tasks using digital slides. Six of the nine evaluating pathologists found that the overall quality of the monitors was good to very good in a similar proportion of cases. 14, 15 Both displays were rated highly in this study, and the differences between them appear to be of a lesser magnitude than in some previous studies, although direct comparison is difficult due to the use of different evaluation metrics and scales. Pathologists have been long accustomed to variability in stain quality and microscope performance and therefore differences in color, contrast, luminance, and resolution. Adaptability borne out of conventional pathology practice may explain why studies have generally shown that variation in color or resolution has only negligible impacts on diagnostic accuracy. If the performance of consumer-and prosumer-grade "off-the-shelf " color displays is sufficient for all or some diagnostic pathology, the lower costs of consumer displays ($500-$2,000 for COTS displays vs $10,000-$17,000 typical of MG monitors used for diagnostic tasks) are likely to generate significant interest in their use, as it has in other areas of medicine. [16] [17] [18] However, it will be important to balance a lower initial purchase cost against diagnostic performance over time. MG displays typically have ancillary monitoring and calibration services available that can maintain and verify performance over time, albeit with additional expense; such services are not usually available for consumer-level displays.
At present, the question of which display to use for diagnostic pathology is open only for secondary diagnosis. In the recent approval of a digital system for primary diagnosis in pathology, the monitor was included within the US Food and Drug Administration definition of the digital pathology "device," and therefore a vendor-specified display is required for primary diagnostic use. To our knowledge, no scientific evidence supports the necessity or superiority of a vendor-supplied display over another of comparable quality. This precedent is concerning, as it may limit competition within the digital pathology space to those vendors able to offer a complete end-to-end digital pathology solution, potentially reducing the rate of innovation and increasing costs. As pathology moves toward a digital practice, it will COTS, commercial off-the-shelf; MG, medical grade. a 1 = poor to 5 = excellent.
© American Society for Clinical Pathology
AJCP / Original article be to the benefit of the field for pathology systems to more closely resemble those used in radiology-a series of interchangeable components from different vendors that have standards-based interoperability.
